BLOG
Neuromodulation Wristband ObeEnd Reduces Heart ...
VANCOUVER, BC, Jan.13, 2025 /PRNewswire/ —WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed for weight and health management. The study revealed...
Neuromodulation Wristband ObeEnd Reduces Heart ...
VANCOUVER, BC, Jan.13, 2025 /PRNewswire/ —WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed for weight and health management. The study revealed...
WAT Medical Sponsors American Headache Society ...
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society from November 14-17 in Scottsdale, AZ. This annual event brought together a multidisciplinary...
WAT Medical Sponsors American Headache Society ...
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society from November 14-17 in Scottsdale, AZ. This annual event brought together a multidisciplinary...
EmeTerm Smart and HeadaTerm 2 Achieve Health Ca...
VANCOUVER, BC, Oct. 16, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly announces a significant achievement: both EmeTerm Smart and HeadaTerm 2 have received Medical Device Licences (MDL) from Health Canada. EmeTerm Smart...
EmeTerm Smart and HeadaTerm 2 Achieve Health Ca...
VANCOUVER, BC, Oct. 16, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly announces a significant achievement: both EmeTerm Smart and HeadaTerm 2 have received Medical Device Licences (MDL) from Health Canada. EmeTerm Smart...
Innovative Anti-Nausea Smartwatch EmeTerm® Smar...
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy...
Innovative Anti-Nausea Smartwatch EmeTerm® Smar...
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy...
WAT Medical Enterprise Unveils HeadaTerm 2 at t...
WAT Medical proudly introduced HeadaTerm 2, an innovative wearable anti-migraine device, at the American Headache Society's 66th Annual Scientific Meeting, held in San Diego, California. The device has recently received...
WAT Medical Enterprise Unveils HeadaTerm 2 at t...
WAT Medical proudly introduced HeadaTerm 2, an innovative wearable anti-migraine device, at the American Headache Society's 66th Annual Scientific Meeting, held in San Diego, California. The device has recently received...
HeadaTerm 2: The Most Affordable FDA Cleared In...
VANCOUVER, BC, April 2, 2024 /PRNewswire/ — WAT Medical Enterprise achieves a major milestone: HeadaTerm 2 receives the OTC clearance from the U.S. Food and Drug Administration (FDA), making it...
HeadaTerm 2: The Most Affordable FDA Cleared In...
VANCOUVER, BC, April 2, 2024 /PRNewswire/ — WAT Medical Enterprise achieves a major milestone: HeadaTerm 2 receives the OTC clearance from the U.S. Food and Drug Administration (FDA), making it...